January 16, 2009
SHPGY Finds New Star in Vyvanse (Zacks.com via Yahoo! Finance)
Vyvanse, the company's new flagship ADHD product, continues to perform well and will be the key driver of the topline.
Filed under Main Content by Content Keyword RSS
Spread the Word!
October 30, 2008
Shire to Sail on New Flagship (Zacks.com via Yahoo! Finance)
Longer-term sales growth will materialize as Vyvanse and other new drugs fill the hole left by generic Adderall XR.
Filed under Main Content by Content Keyword RSS
Spread the Word!
August 19, 2008
Barr Pharma a Hold on Teva Buyout (Zacks.com via Yahoo! Finance)
We moved back to a Hold rating from Sell following the recent announcement regarding the takeover of the company by Teva Pharmaceuticals.
Filed under Main Content by Content Keyword RSS
